Vascular-targeted photodynamic therapy with BF2-chelated Tetraaryl-Azadipyrromethene agents: a multi-modality molecular imaging approach to therapeutic assessment.

Byrne, A T; O'Connor, A E; Hall, M; Murtagh, J; O'Neill, K; Curran, K M; Mongrain, K; Rousseau, J A; Lecomte, R; McGee, S; Callanan, J J; O'Shea, D F; Gallagher, W M

Byrne, A T; O'Connor, A E; Hall, M; Murtagh, J; O'Neill, K; Curran, K M; Mongrain, K; Rousseau, J A; Lecomte, R; McGee, S; Callanan, J J; O'Shea, D F; Gallagher, W M.

Affiliation

Byrne AT; UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland.

Br J Cancer ; 101(9): 1565-73, 2009 Nov 03.

Article in En | MEDLINE | ID: mdl-19826417

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Photochemotherapy / Pyrroles / Photosensitizing Agents / Mammary Neoplasms, Experimental Limits: Animals / Female / Humans Language: En Journal: Br J Cancer Year: 2009 Document type: Article Affiliation country: Irlanda Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google